Safeguard Scientifics, Inc. (SFES)
OTCMKTS · Delayed Price · Currency is USD
0.4500
+0.0600 (15.38%)
Jul 28, 2026, 10:08 AM EST

Safeguard Scientifics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Income
-5.68-5.68-4.78-6.45-8.17-9.48
Net Income
-9.83-9.83-14.2627-37.6254.56
Earnings Per Share
-0.61-0.61-0.871.36-1.812.64
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
9.59.520.1529.2915.625.03
Total Debt
1.251.251.682.052.382.78
Net Cash (Debt)
8.258.2518.4727.2413.2222.25
Net Cash Growth
-55.34%-55.34%-32.19%106.00%-40.58%-
Net Cash Per Share
0.510.511.131.370.641.08

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec '23 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-3.31-3.31-3.26-8.15-8.14-19.97
Capital Expenditures
------
Free Cash Flow
-3.31-3.31-3.26-8.15-8.14-19.97
Free Cash Flow Growth
------

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PE Ratio
---4.49-4.16
Forward PE
-5.125.125.125.125.12